Improving blood tests for diagnosing complex cancers
Optimizing blood biopsy in cancers with low mutation burden and high structural complexity
This study is looking at ways to make blood tests better at finding certain types of cancer, like sarcomas, by checking for tiny bits of DNA and RNA from tumor cells, so that doctors can give you more personalized treatment options when other tests are tricky.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10917276 on NIH RePORTER |
What this research studies
This research focuses on enhancing liquid biopsy techniques, which are non-invasive blood tests that detect cancer by analyzing DNA and RNA released by tumor cells. The study aims to improve the accuracy of these tests for cancers that have a low mutation burden and high structural complexity, such as certain sarcomas. By exploring new methods to assess DNA fragment patterns and methylation status, the research seeks to provide more reliable information about cancer types and treatment responses. This could help tailor therapies to individual patients, especially when traditional methods like imaging are difficult.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with structurally complex cancers, such as osteosarcoma or Ewing’s sarcoma.
Not a fit: Patients with cancers that have a well-defined mutation landscape, such as common lung or breast cancers, may not benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and personalized cancer diagnostics and treatment options for patients with complex cancers.
How similar studies have performed: Other research has shown promise in using advanced liquid biopsy techniques for cancer detection, indicating that this approach may lead to significant advancements in the field.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Gardner, Heather Lynn — Tufts University Boston
- Study coordinator: Gardner, Heather Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.